Redox/pH-Responsive 2-in-1 Chimeric Nanoparticles for the Co-Delivery of Doxorubicin and siRNA

The co-delivery of chemotherapy drugs and gene-suppressing small interfering RNA (siRNA) show promise for cancer therapy. The key to the clinical realization of this treatment model will be the development of a carrier system enabling the simultaneous delivery (“co-delivery” instead of combinatorial...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hsi-Chin, Kuo, Wei-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703840/
https://www.ncbi.nlm.nih.gov/pubmed/34960912
http://dx.doi.org/10.3390/polym13244362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703840/
https://www.ncbi.nlm.nih.gov/pubmed/34960912
http://dx.doi.org/10.3390/polym13244362

Ejemplares similares